You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ultra-small superparamagnetic iron oxide nanoparticle

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Magnetic Resonance Imaging Trial in Xinxiang (polysaccharide superparamagnetic iron oxide injection)

Completed
  • Magnetic Resonance Imaging
  • polysaccharide superparamagnetic iron oxide injection
  • Xinxiang, Henan, China
    Xinxiang Central Hospital
Aug 23, 2023

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)

Completed
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Chronic Kidney Diseases Trial in Nanjing (domestic polysaccharide superparamagnetic iron oxide nanoparticle)

Recruiting
  • Chronic Kidney Diseases
  • domestic polysaccharide superparamagnetic iron oxide nanoparticle
  • Nanjing, Jiangsu, China
    First Affiliated Hospital of Nanjing Medical University
Jan 15, 2022

Head Neck Cancer Trial in Houston (Magnetic Resonance Imaging (MRI), Ferumoxytol)

Terminated
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 15, 2021

PET MRI in Coronary Artery Disease

Active, not recruiting
  • Coronary Artery Disease
  • PET/MRI
  • MRI
  • Edinburgh, Scotland, United Kingdom
    Royal Infirmary of Edinburgh
Jun 6, 2022

Breast Cancer, Sentinel Lymph Node Trial in Gothenburg (Superparamagnetic Iron Oxide)

Recruiting
  • Breast Cancer
  • Sentinel Lymph Node
  • Superparamagnetic Iron Oxide
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
Oct 26, 2022

Diabetes, Magnetic Resonance Imaging Trial in Beijing (Polysaccharide superparamagnetic iron oxide injection)

Completed
  • Diabetes
  • Magnetic Resonance Imaging
  • Polysaccharide superparamagnetic iron oxide injection
  • Beijing, Beijing, China
    Beijing Luhe Hospital, Capital Medical University
Sep 27, 2023

Pancreatic Cancer, Periampullary Cancer Trial in Nijmegen (USPIO-enhanced MRI)

Terminated
  • Pancreatic Cancer
  • Periampullary Cancer
  • USPIO-enhanced MRI
  • Nijmegen, Netherlands
    Radboudumc
Sep 19, 2021

Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • +2 more
  • Ferumoxytol infusion
  • +2 more
  • Salt Lake City, Utah
    University of Utah Health Imaging and Neurosciences Center
Jun 22, 2022

Breast Cancer Trial in Gothenburg (MagTrace only, MagTrace and Magseed)

Recruiting
  • Breast Cancer
  • MagTrace only
  • MagTrace and Magseed
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
Nov 22, 2022

Migraine Headache, Migraine Without Aura Trial in Glostrup (Feraheme, Cilostazol, USPIO-MRI)

Completed
  • Migraine Headache
  • Migraine Without Aura
  • Glostrup, Denmark
    Rigshospitalet Glostrup
Jul 26, 2022

Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

Not yet recruiting
  • Extramedullary Myeloma
  • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2022

Breast Cancer, Sentinel Lymph Node Trial in Hong Kong (sentinel lymph node biopsy procedure)

Recruiting
  • Breast Cancer
  • Sentinel Lymph Node
  • sentinel lymph node biopsy procedure
  • Hong Kong, Hong Kong
    University of Hong Kong
Mar 10, 2022

Magnetic Resonance Imaging, Chronic Kidney Diseases Trial in Beijing (Polysaccharide superparamagnetic ferric oxide injection)

Not yet recruiting
  • Magnetic Resonance Imaging
  • Chronic Kidney Diseases
  • Polysaccharide superparamagnetic ferric oxide injection
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
Jan 16, 2023

Controlling Protein Corona for Optimized Nanomedicine

Not yet recruiting
  • Coagulation Tests
  • blood tests
  • Dijon, France
    CHU DIJON BOURGOGNE - laboratoire mixte
Jan 10, 2023

Apical Periodontitis, Pulp Disease, Dental Trial in Philadelphia (Iron oxide nanoparticles treatment Ferumoxytol/H2O2, NaOCl,

Completed
  • Apical Periodontitis
  • Pulp Disease, Dental
  • Iron oxide nanoparticles treatment Ferumoxytol/H2O2
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 25, 2023

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging

Recruiting
  • Heart Aneurysm
  • Superparamagnetic Iron Oxide Nanoparticles
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Nov 18, 2023

Glioblastoma Trial (MRI scan using USPIO particles)

Not yet recruiting
  • Glioblastoma
  • MRI scan using USPIO particles
  • (no location specified)
Dec 15, 2022

Delayed SLND for Breast Cancer Undergoing Primary Systemic

Active, not recruiting
  • Breast Cancer
  • +2 more
  • SLND or TAD by the magnetic technique (SPIO)
  • Uppsala, Sweden
    Uppsala University Hospital
Aug 2, 2023

Ferumoxytol Enhanced Hyperfine Low Field Strength MRI

Completed
  • Anemia, Hemolytic
  • Hyperfine Portable MRI
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Dec 16, 2022

DCIS, Breast Cancer, Breast Tumors Trial in Hong Kong, Sweden, United States (Delayed SLND, Late SLND)

Recruiting
  • DCIS
  • +3 more
  • Delayed SLND
  • Late SLND
  • Houston, Texas
  • +8 more
Mar 14, 2022

Magseed and Magtrace Localization for Breast Cancer

Recruiting
  • Breast Carcinoma
  • Breast Carcinoma Metastatic in Lymph Node
  • Magseed
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 16, 2021

Does Intravenous Iron Therapy Decrease Serum Phosphorous Levels?

Completed
Has Results
  • Chronic Renal Failure
  • non interventional
  • Afula, Israel
    Haemek medical center
Aug 8, 2022

Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

Suspended
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023